Lipoprotein(a): Looking ahead

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 5, 2005, Pages 331-333

  Scanu, Angelo M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27644567649     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.07.006     Document Type: Editorial

References (6)

1. Scanu AM. Lipoprotein(a). In: Fuster V, Topol E, Nabel EG, editors. Atherothrombosis and coronary heart disease. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 123-8.
2. Berglund L, Ramakrishnan R. Lipoprotein(a), an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004;24:2219-26.
3. Edelstein C, Pfaffinger D, Hinman J, Miller E, Lipkind G, Tsimikas S, et al. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential proinflammatory properties to human apolipoprotein(a). J Biol Chem 2003;278:52841-7.
4. Scanu AM. Lipoprotein(a): coping with heterogeneity. N Engl J Med 2003;22:2089-90.
5. Marcovina S, Koschinsky ML, Albers J, Skarlatos S. Report of the National Heart Lung and Blood Institute workshop on lipoprotein(a) and cardiovascular disease. Recent advances and future directions. Clin Chem 2003;49:1788-96.
6. Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna D, et al. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia. Nutr Metab Cardiovasc Dis 2004;14: 193-9.